February 13, 2023
  • An analysis conducted by the Health Care Cost Institute found that employer-sponsored health plans pay significantly more than Medicare for costly physician-administered drugs. Researchers found that between 2016 and 2020 price markups increased for five of the top 10 drugs that account for the most spending and more than doubled for three. Furthermore, workplace plan markups over Medicare prices were especially high for these drugs. The authors said policies to reduce private plan prices for physician-administered drugs are important to control overall health spending and ensure access to new products for the U.S. population that has coverage through work. (Study here)